An observational study of oral tofacitinib, baricitinib, upadacitinib and systemic steroids in refractory vitiligo, Mendeley Supplements.

1. Supplemental Materials including: Supplementary Figure 1: The VASI score in four groups at month 0, 3, and 6. Supplementary Figure 2: The VASI improvement in four groups at month 0, 3, and 6. Supplementary Figure 3: Serum levels of CXCL10 and CCL20 in four groups at month 0, 3, and 6. Supplementary Figure 4: Clinical photographs using a wood light of 4 patients receiving different monotherapy during the follow-up. (T, tofacitinib; B, baricitinib; U, upadacitinib; S, steroids). 2.Supplemental Methods